Urbana, IL, United States of America

Erica Nicole Parker

USPTO Granted Patents = 2 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2023-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Erica Nicole Parker

Introduction

Erica Nicole Parker is a prominent inventor based in Urbana, IL (US). She has made significant contributions to the field of antibacterial compounds, particularly those effective against Gram-negative pathogens. With a total of 2 patents to her name, her work is crucial in addressing microbial infections.

Latest Patents

Her latest patents include "Ribocil C antibiotics effective for Gram-negative pathogens." This patent discloses antibacterial compounds that accumulate in Gram-negative bacteria. It details methods of preparing these compounds and their use in inhibiting or killing microbes, as well as treating microbial infections. The compounds selected for conversion to potential Gram-negative antibacterial agents were identified based on their low globularity and low flexibility. Amine substituents were strategically added to enhance their antibacterial activity against Gram-negative bacteria. Another patent titled "Antibiotics effective for Gram-negative pathogens" shares similar findings and methodologies.

Career Highlights

Erica is affiliated with the University of Illinois, where she conducts her research and development. Her work has garnered attention for its innovative approach to combating bacterial infections, which are a significant public health concern.

Collaborations

Some of her notable coworkers include Paul Joseph Hergenrother and Emily Jane Geddes, who contribute to her research endeavors.

Conclusion

Erica Nicole Parker's contributions to the field of antibacterial compounds highlight her innovative spirit and dedication to improving public health. Her patents represent a significant advancement in the fight against Gram-negative bacterial infections.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…